NCT03278600

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

The Value of Tissue-of-origin (ORIGIN-PanCA○R) Profiling in Predicting Primary Site and Directing Therapy in Patients With Cancer of Unknown Primary: a Prospective Randomized Controlled Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 182 (actual)
• Sponsor: Fudan University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to evaluate the value of tissue-of-origin (ORIGIN-PanCA○R) profiling in predicting primary site and directing therapy in patients with cancer of unknown primary.

Conditions

• Cancer of Unknown Primary Site

Interventions

Type	Name	Description
GENETIC	tissue-of-origin (ORIGIN-PanCA○R) profiling	90-gene assay to predict the primary tumor site

Timeline

• Start date: 2017-09-18
• Primary completion: 2021-03-18
• Completion: 2021-03-18
• First posted: 2017-09-11
• Last updated: 2022-01-24

Locations

1 site across 1 country: China